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Introduction
Cannabis has a long history of medicinal use, dating
back thousands of years (1). However, with the
discovery of morphine, hypodermic needles and other
fast acting synthetic opioids in the ninetieth and the
turn of the twentieth century- cannabis use declined as
a medication(2).
For most of the past six decades, cannabis has
been considered a recreational drug, and was
considered illegal in many jurisdictions. Yet in the
past few years its association with medicine has made
a dramatic comeback. As illustrated in figure 1, over
the past six years (2010-2016) the terms “medical
cannabis” and “medical marijuana” has seen a
4- to 5-fold increase in references based on a
historical trend analysis of the terms noted in the
PubMed database. It would appear that the term
medical cannabis is most often used over medical
marijuana, in the emerging literature.
In the past several years, claims on the potential
for cannabis to treat, cure and prevent a number of
diseases and conditions has led some to query
whether these claims are overstated.
A game changer for medical cannabis has been
the ability to consume it without a need to actually
inhale it along with other negative products of
combustion. Newer technologies that allow for the
vaporization of the full plant has made it less of a
health concern (3).
Noticeably the evidence on medical cannabis is
lacking in both quality and quantity. To date most of
the research has been conducted in Israel, however,
with cannabis set to be legalized for use in Canada (4)
and in a recent move in the United States, by the
Obama administration (5), to remove barriers should
allow researchers greater access to medical cannabis
for testing in well-designed clinical trials.
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Figure 1. Number of article titles using the terms: medical cannabis and medical marijuana in PubMed.

In Canada, the federal marijuana regulations were
updated in the summer of 2016 with the introduction
of the Access to Cannabis for Medical Purposes
Regulations (ACMPR). The aim of this newly
update regulation (ACMPR) is to treat marijuana like
other psychoactive drugs used for medical purposes.
Many of the Colleges (eight provincial) in Canada
prohibit or at best strongly discourage its members
from dispensing, providing or accepting delivery of
marijuana for medical purposes (6). Of major concern
for most Colleges has been a lack of good evidence
on both medical risks and therapeutic benefits of
marijuana- intimating that physicians’ currently
prescribing cannabis may be falling short of a fulsome
informed consent process.
The typical recommendation for Canadian
physicians is that medical cannabis should not be a
first line therapy and that documentation should
outline that conventional therapies were attempted but
were not successful (6). The legal defense
organization for physicians practicing in Canada- the
Canadian Medical Protective Association (CMPA),
updated its guidance document following the passing
of ACMPR regulations- a cursory read through this
document quickly identifies a less than positive
endorsement for physicians, highlighting mainly

potential risks and limitations to physicians
potentially interested in adding medical cannabis to
their treatment recommendations.
As the medical community has been slow to startnoticeable in the grey literature is the proliferation of
website by patient and advocacy groups making
claims that cannabis has the potential to treat ailments
and symptoms ranging from AIDS related illness,
Asperger’s, Bulimia, carpal tunnel syndrome to
whiplash- making the differentiation between the
miraculous and mere hype all the more challenging to
identify (7-9).
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